首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Correlation between upper and lower airway inflammations in patients with combined allergic rhinitis and asthma syndrome: A comparison of patients initially presenting with allergic rhinitis and those initially presenting with asthma
【2h】

Correlation between upper and lower airway inflammations in patients with combined allergic rhinitis and asthma syndrome: A comparison of patients initially presenting with allergic rhinitis and those initially presenting with asthma

机译:合并过敏性鼻炎和哮喘综合征的患者的上下气道炎症之间的相关性:最初患有过敏性鼻炎的患者与最初患有哮喘的患者的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Allergic rhinitis (AR) and asthma often coexist. The terminology combined allergic rhinitis and asthma syndrome (CARAS) was introduced to describe patients with combined AR and asthma. The aim of the present study was to evaluate the correlation between eosinophilic inflammation in the upper and lower airways of patients with CARAS. Stable patients with CARAS initially presenting with AR or asthma were recruited. Healthy subjects and patients with AR alone were recruited as controls. Clinical characteristics, including disease history, lung function, nasal airway inspiratory resistance and upper and lower airway eosinophilic inflammation were evaluated and compared. A total of 73 subjects (22 patients with CARAS initially presenting with AR, 15 patients with CARAS initially presenting with asthma, 25 patients with AR alone and 11 healthy subjects) were studied. The nasal symptoms visual analogue scale scores at the week prior to enrollment and nasal airway inspiratory resistances were comparable among the groups. The percentage of predicted forced expiratory volume in 1 sec and percentage of predicted maximal middle expiratory flow in patients with CARAS initially presenting with asthma were significantly lower compared with the other three groups (P<0.05). No significant different in the percentage of eosinophils in the nasal lavage was observed between patients with CARAS and those with AR only; however, it was significantly increased compared with healthy subjects (P<0.05). The fractional concentration of exhaled nitric oxide and percentage of eosinophils in the sputum were significantly increased in patients with CARAS compared with those in the AR only and healthy subject groups (P<0.05). The difference in the percentage of eosinophils in the nasal lavage and sputum between patients with CARAS initially presenting with AR and initially presenting with asthma was not significant; however, a positive correlation between the percentage of eosinophils in the upper and lower airways was present in patients with CARAS initially presenting with AR only (r=0.526, P=0.030).
机译:过敏性鼻炎(AR)和哮喘经常并存。引入术语变应性鼻炎和哮喘综合症(CARAS)来描述AR和哮喘合并的患者。本研究的目的是评估CARAS患者上,下呼吸道嗜酸性粒细胞炎症之间的相关性。招募了最初表现为AR或哮喘的CARAS稳定患者。招募健康受试者和仅患有AR的患者作为对照。评价并比较了包括病史,肺功能,鼻气道吸气阻力以及上,下气道嗜酸性粒细胞炎症在内的临床特征。共研究了73名受试者(22名最初出现AR的CARAS患者,15名最初出现哮喘的CARAS患者,25名单独AR的患者和11名健康受试者)。入组前一周的鼻部症状视觉模拟量表评分和鼻气道吸气阻力在各组之间相当。与其他三组相比,最初出现哮喘的CARAS患者在1秒内预计的强制呼气量百分比和预计的最大中间呼气流量百分比均显着降低(P <0.05)。患有CARAS的患者和仅患有AR的患者在鼻灌洗液中嗜酸性粒细胞百分比没有显着差异;然而,与健康受试者相比,其显着增加(P <0.05)。与仅AR组和健康受试者组相比,CARAS患者的呼出气中一氧化氮浓度分数和嗜酸性粒细胞百分比显着增加(P <0.05)。最初表现为AR和最初表现为哮喘的CARAS患者之间,鼻腔灌洗液和痰中嗜酸性粒细胞百分比的差异不显着;然而,最初仅表现为AR的CARAS患者中,上呼吸道和下呼吸道的嗜酸性粒细胞百分比之间呈正相关(r = 0.526,P = 0.030)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号